Children learned how to safely cross streets and stay aware around traffic as part of Volvo's "Stop, Look, Wave" Program. Donald Trump says Reflecting Pool looks "perfect" after "gruesome" vandalism ...

On the morning of Nov. 13, Daniel and Melissa Yue walked out to their Elkridge driveway and found their 2023 Toyota Highlander gone. Three miles away in Ellicott City, a 2014 Lexus had also been ...

Subscription roll-out to be completed across markets in mid-2027 New model seen boosting fee income, ING executive says June 10 (Reuters) - ING (INGA.AS), opens new tab launched a new ...

ING Groep NV is introducing a subscription banking model for retail clients globally, as the Dutch lender looks to cater to customer demand for greater transparency and personalization while boosting ...

Anthropic has finally released a version of Claude Mythos, its most powerful model yet, but most people will experience it under a different name. The company just announced Claude Fable 5, its first ...

WASHINGTON (AP) — The Senate blocked an extension early Friday of a key surveillance program used by U.S. intelligence agencies as concerns mounted over President Donald Trump's selection of federal ...

Elected officials and residents gathered Monday for a groundbreaking ceremony on the 1600 block of West Venango Street. Work has already begun on Venango Street, where 22 three-bedroom homes for ...

Volvo Cars reached an agreement with the Trump administration that allows the automaker to continue to sell vehicles in the U.S., avoiding a ban on Chinese-connected vehicle technology. The Swedish ...

Much to the chagrin of its dealers, Volvo has embraced EVs with an enthusiasm and openness for experimentation matched by few other established automakers. It started in 2021 by repurposing a ...

Volvo said it’s lowering the threshold for a premium electric SUV after opening orders for the all-new EX60 on Monday. The 2027 Volvo EX60 starts at $58,400, which is nearly $23,000 cheaper than the ...

Actimab-A combinations enhanced in vivo AML cell killing across multiple preclinical models, independent of mutation status, when combined with standard-of-care targeted and non-targeted therapies ...